The latest update on Semaglutide, as we understand that there has been some confusion and various statements from state boards and the FDA regarding compounding Semaglutide.
We would like to assure you that Semaglutide continues to be listed on the FDA shortage list, which is something we check on a daily basis.
Furthermore, we want to clarify that our pharmacy uses the active pharmaceutical ingredient, Semaglutide, and NOT the sodium salt form, also known as Sodium Semaglutide which the warning was issued for.
We take great pride in our commitment to quality and only use FDA-registered facilities. As such, we are following all necessary guidelines and staying proactive to ensure proper communication.